In 1364 healthy Brazilian adults, single-dose V181 was non-inferior to Butantan-DV on day-28 neutralising antibody GMT ratios for DENV-1 and DENV-2 but not DENV-3 and DENV-4; seroconversion was non-inferior for all four serotypes. Both were generally well tolerated.
RCTn = 1,364
Alexanderian et al. Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial